Alamar Biosciences, Inc. (ALMR) vs Dyne Therapeutics, Inc. (DYN)
A side-by-side comparison of Alamar Biosciences, Inc. and Dyne Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALMR
Alamar Biosciences, Inc.
$38.13HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
DYN
Dyne Therapeutics, Inc.
$15.44HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALMR vs DYN
growth of $100 · dividends reinvested · last 1yALMR +73.3% (+73.3%/yr)DYN -22.5% (-22.5%/yr)ALMR compounded faster over this window
ALMR DYN
ALMR vs DYN: by the numbers
- •DYN is the larger company ($2.88B vs $2.64B market cap).
- •Both run net losses; DYN's is the smaller (0.00% vs -40.18% net margin).
Metrics side by side
Valuation
| Metric | ALMR | DYN |
|---|---|---|
| P/B ratio | 8.45 | 4.11 |
Profitability
| Metric | ALMR | DYN |
|---|---|---|
| Gross margin | 56.20% | 0.00% |
| Operating margin | -42.22% | 0.00% |
| Net margin | -40.18% | 0.00% |
| ROE | N/A | -73.97% |
| ROIC | -26.95% | -58.28% |
Growth (annualized)
| Metric | ALMR | DYN |
|---|---|---|
| Total return CAGR (5Y) | N/A | -0.38% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.